Prognostic Role of Heart Rate Variability in Patients with ST-Segment Elevation Acute Myocardial Infarction Treated by Primary Angioplasty
- 1 January 2013
- journal article
- research article
- Published by S. Karger AG in Cardiology
- Vol. 124 (1), 63-70
- https://doi.org/10.1159/000345779
Abstract
Objectives: The aim of our study was to assess the prognostic value of heart rate variability (HRV) in ST-segment elevation acute myocardial infarction (STEMI) patients treated by percutaneous transluminal coronary angioplasty (PTCA) and optimal medical therapy. Methods: We enrolled 182 consecutive patients with a first STEMI (59.1 ± 11 years; 82.4% men) treated by primary PTCA. HRV was assessed on 24-hour Holter ECG recordings before discharge and 1 and 6 months after discharge. The primary end point was the occurrence of major clinical events (MCE), defined as death or new acute myocardial infarction (AMI). Results: At a follow-up of 42 ± 23 months, MCE occurred in 14 patients (7.6%; 3 deaths and 11 re-AMIs). HRV parameters before discharge were significantly lower in patients with MCE, with standard deviation of all RR intervals (SDNN) and very low frequency and low frequency (LF) amplitude being the most predictive variables. HRV assessed at follow-up instead did not significantly predict MCE. At multivariate analysis, only SDNN (HR 0.97; p = 0.02) and LF (HR 0.90; p = 0.04) remained significantly associated with MCE. Lower tertile SDNN and LF values were associated with a multivariate HR of 3.91 (p = 0.015) and of 2.92 (p = 0.048), respectively. Similar results were observed considering re-AMI only as the end point. Conclusions: In STEMI patients treated by PTCA, HRV assessed before discharge was an independent predictor of MCE and re-AMI.Keywords
This publication has 16 references indexed in Scilit:
- Prognostic value of heart rate variability after acute myocardial infarction in the era of immediate reperfusionHerzschrittmachertherapie + Elektrophysiologie, 2008
- Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarctionThe Lancet, 1998
- Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative reviewJAMA, 1997
- Prognostic Significance of Heart Rate Variability in Post–Myocardial Infarction Patients in the Fibrinolytic EraCirculation, 1996
- Heart rate variability: Standards of measurement, physiological interpretation, and clinical useEuropean Heart Journal, 1996
- A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial InfarctionThe New England Journal of Medicine, 1993
- Frequency domain measures of heart period variability and mortality after myocardial infarction.Circulation, 1992
- Multicenter patency trial of intravenous anistreplase compared with streptokinase in acute myocardial infarction. The TEAM-2 Study Investigators.Circulation, 1991
- Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.Circulation, 1987
- Decreased heart rate variability and its association with increased mortality after acute myocardial infarctionThe American Journal of Cardiology, 1987